Why the study?
Does cilostazol prevent secondary stroke in patients with a history of previous stroke?
Does cilostazol prevent secondary stroke in patients with a history of previous stroke?
This review highlights the potential of cilostazol for secondary stroke prevention worldwide, advocating for further randomized trials in Western populations to support its broader use beyond Asia.
No takes yet. Share an insight, caveat, or question.
Cilostazol should not yet change practice for secondary stroke prevention; leaves open broader use pending Western randomized trials.
Noma et al. (2018) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: